|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02652 CF PHARMTECH
Nominal 
() | 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Turnover | 607,752 | 9.225% | 556,421 | 349,127 |
| Cost of Sales | (116,380) | 17.659% | (98,913) | (81,672) |
| Gross Profit | 491,372 | 7.402% | 457,508 | 267,455 |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (1,328) | 116.993% | (612) | (1,386) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (74) | -25.253% | (99) | 0 | |
| Profit / (Loss) before Taxation | 19,184 | -14.521% | 22,443 | (70,615) | |
| Taxation | 1,904 | -79.489% | 9,283 | 21,216 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | |
| Others | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 21,088 | -33.531% | 31,726 | (49,399) | |
| 2024/12 - Final RMB(K¥) | %Chg (Compare to Final) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,175 | -- | (3,757) | (4,124) |
| Depreciation & Amortisation | 60,192 | 11.148% | 54,155 | 38,894 |
| Directors' Emoluments | 7,659 | 11.501% | 6,869 | 13,355 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| EPS (cts) | 6.000 | -33.333% | 9.000 | -13.000 |
| DPS (cts) | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- |
| Cash flow per share ($) | 0.260 | -- | 0.314 | 0.123 |
| NBV per share ($) | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 30/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 21,088 |
| %Change | -33.531% |
| EPS / (LPS) | RMB 0.060 |
| NBV Per Share (¥) | RMB -- |